期刊文献+

深圳市婴儿感染B族链球菌的克林霉素诱导型耐药研究

Inducible Resistance to Clindamycin in Group B Streptococcus Isolated from Infants in Shenzhen
下载PDF
导出
摘要 目的:了解婴儿感染B族链球菌(GBS)的红霉素、克林霉素耐药率及大环内酯-林可酰胺-链阳菌素B(MLSB)类抗菌药物耐药表型。方法:采用纸片扩散法检测婴儿感染GBS菌株对红霉素、克林霉素的敏感性,D试验检测红霉素对克林霉素的诱导耐药性。结果:本研究纳入的患儿中男16例,女15例,年龄3 h^5个月。GBS对红霉素、克林霉素的耐药率分别为80.6%、77.4%;对红霉素、克林霉素同时敏感的GBS 3株,占9.7%;对红霉素耐药、对克林霉素敏感的2株,占6.5%。23例(92.0%)内在型耐药(cMLSB),2例(8.0%)M型耐药,未发现诱导型耐药。结论:婴儿感染的B族链球菌对红霉素、克林霉素耐药率高,MLSB耐药表型以cMLSB为主,未发现诱导型耐药。 Objective: To explore the resistance rate of group B Streptococcus (GBS) to erythromycin and clindamycin and phenotype of resistance to macrolides, lincosamides and type B streptogramin (MLSB)in infected infants. Methods: The antimicrobial susceptibility of GBS to erythromycin and clindamycin were determined by the disk diffusion technique in Mueller-Hinton agar. The inducible resistance of erythromycin to elindamyein was detected by D test. Results: Thirty one strains were isolated from 31 children (16 boys, 15 girls). The ages ranged from 3 h to 5 months. Among the 31 GBS-positive cultures, erythromycin resistance was found in 25 strains (80. 6% ) , clindamycin resistance was found in 24 strains (77.4%). Three GBS isolates were susceptible to both erythromyein and clindamycin. Two isolates were resistant to erythromyein whilst susceptible to clindamycin. Among the 25 erythromycin-resistant isolates, the constitutive MLSB (eMLSB) was indentified in 23 eases(92.0% ). The iMLSB phenotype was not found. Conclusion: Rates of GBS resistance to erythromycin and clindamycin in infants are high. The eMLSB phenotype is common and iMLSB is not found.
出处 《儿科药学杂志》 CAS 2017年第5期1-3,共3页 Journal of Pediatric Pharmacy
基金 深圳市科技计划项目 编号JCYJ20150403100317058 深圳市卫生计生系统科研项目 编号201402045
关键词 婴儿 B族链球菌 克林霉素 耐药 infant group B streptococcus clindamycin resistance
  • 相关文献

参考文献4

二级参考文献54

  • 1申阿东,张桂荣,王咏红,杨永弘.B组链球菌的耐药性及红霉素耐药基因检测研究[J].中华儿科杂志,2005,43(9):661-664. 被引量:15
  • 2Wu JH,Chen CY,Tsao PN. Neonatal sepsis:a 6-year analysis in a neonatal care unit in Taiwan[J].Pediatr Neonatol,2009,(03):88-95.
  • 3沈晓明;王卫平.儿科学[M]北京:人民卫生出版社,2010123-125.
  • 4Tiskumara R,Fakharee SH,Liu CQ. Neonatal infections in Asia[J].Arch Dis Child Feta J Neonatal Ed,2009,(02):144-148.
  • 5Cagno CK,Pettit JM, Weiss BD. Prevention of perinatal group B streptococcal disease:updated CDC guideline[J]. Am Faro Physi- cian,g012,86(1) :59-65.
  • 6Schugk J, Harjola VP, Sivonen A, et al. A clinical study of beta haemolytic groups A, B, C and G streptococcal bacteremia in a- dults over an 8-year period[J]. Scand J Infect Dis, 1997,29 (3): 233-238.
  • 7I.indahl G, Stlhammar-Carlemalm M, Areschoug T. Surface pro- teins of Streptococcus agalactiae and related proteins in other bac terial pathogens[J]. Clin Microbiol Rev, 2005,18 ( 1 ) : 102-127.
  • 8Granizo JJ,Aguilar L,Casal J, et al. Streptococcus pyogenes re- sistance to erythromycin in relation to macrolide consumption in Spain (1986-1997)[J]. J Antimicrob Chemother, 2000,46(6): 959-964.
  • 9Heelan JS, Hasenbein ME, Mcadam AJ. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin[ J]. J Clin Microbiol, 2004,42 ( 3 ) : 1263-1264.
  • 10A16s JI,Aracil B,Oteo J, et al. High prevalence of erythromycin- resistant, clindamycin/miocamyciwsusceptihle ( M phenotype ) Streptococcus pyogenes:results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting[J]. J Antimicrob Chemother, 2000,45(5): 605-609.

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部